Skip to Main Content

Paper Details

Virologic suppression, treatment adherence, and improved quality of life on a once-daily efavirenz-based regimen in treatment-Naïve HIV-1-infected patients over 96 weeks.
HIV Clin Trials
21
2009
HIV, HIV RNA, HIV-1, HIV-1-infected, Patients, didanosine, efavirenz, lamivudine, patients, stavudine, virologic failure
Author NameAffiliation
Dushyantha JayaweeraMiller School of Medicine, University of Miami
  • 1 - 1

Datasets

Release 1.2